Parkinson's Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasures.

Autor: Haines DD; Northwell Health System, New York, NY, United States., Trushin MV; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation., Rose S; Bioengineering and Nanotechnology MA Program, Harvard University, Cambridge, Massachusetts, 01254, United States., Bernard IAS; Department of Biological Sciences, Universidad de Sonora, Blvd. Luis Encinas y Rosales, Hermosillo, Sonora, Mexico., Mahmoud FF; Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Kuwait.

Publikováno v: Current pharmaceutical design [Curr Pharm Des] 2018; Vol. 24 (20), pp. 2317-2321.